IPO Name: Glenmark Life Sciences Ltd.
Parent Company : Glenmark Pharma
Issue Opens On : Tues, July 27, 2021
Issue Closes On : Thurs, July 29, 2021
Issue Details : Fresh Issue of Rs.1160 Crs + OFS upto 63,00,000 Eq Shares
Face Value. : 2/-
Price Band : Rs.695 - Rs.720
Bid Lot : 20 Equity Shares
Issue Size ( Rs.) : Rs 1,513.6 crore
Issue Allocation : 50% QIB ( Rs.807 Crs ), 15% NIB ( Rs.242 Crs ) & 35% Retail ( Rs.565 Crs )
Listing : BSE and NSE
Company overview: Leading developer and manufacturer of select high-value APIs (Active Pharmaceutical Ingredients) in chronic therapeutic areas with a global reach
Registrar to the issue: KFin Technologies Pvt. Ltd.
Lead Managers: Kotak Mahindra Capital Co. Ltd., BofA Securities India Ltd., Goldman Sachs (India) Securities Pvt. Ltd., DAM Capital Advisors Ltd., BOB Capital Markets Ltd. and SBI Capital Markets Ltd.
Our View: Current times have set a clear path for pharma and healthcare Sectors. An IPO of a pharma company with a global reach and a robust parent comapny structure is quite an opportunity to grab
The Pandemic shook the economy in a way which left people unemployed, underpaid and with sky rocketing inflation. FDs RDs and saving bank accounts are giving us a return as low as half of the inflation rate
So in such times MF becomes the most powerful tool to fight inflation and create wealth in a long run
We, at Wealthpool, value our clients equally. The client with an investment amount of as low as INR 500 is equally serviced and valued as that of a client with investment of INR 500 Cr
Convenience of transacting and trust are the fundamental building blocks of Wealthpool MF Services
Wealthpool is your one stop solution for all the MF queries
Mutual Fund investment is itself a one solution for most of your financial worries and we figure it out for you to when to invest, in which scheme to invest or for how long to remain invested and even, when not to invest